Hurley Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$331K Buy
1,250
+3
+0.2% +$791 0.16% 77
2026
Q2
$317K Sell
1,247
-1
-0.1% -$233 0.16% 77
2026
Q1
$305K Buy
1,248
+26
+2% +$6.06K 0.16% 70
2025
Q4
$253K Buy
1,222
+95
+8% +$18.8K 0.14% 70
2025
Q3
$209K Buy
1,127
+7
+0.6% +$1.2K 0.12% 88
2025
Q2
$171K Buy
1,120
+2
+0.2% +$307 0.12% 79
2025
Q1
$185K Sell
1,118
-4
-0.4% -$626 0.14% 84
2024
Q4
$164K Buy
+1,122
New +$174K 0.13% 76

Other funds holding JNJ

Hurley Capital's JNJ Position: Q3 2026 in Review

Hurley Capital increased its Johnson & Johnson (JNJ) stake by 0.24% in Q3 2026, buying an estimated $791 and bringing the position to 1,250 shares worth $331K. The position accounts for 0.16% of the portfolio, ranked #77.

Hurley Capital first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 3,191 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Hurley Capital held 1,250 shares of Johnson & Johnson worth $331K as of Q3 2026.
  • Hurley Capital bought 3 Johnson & Johnson shares in Q3 2026, an estimated $791.
  • Johnson & Johnson made up 0.16% of Hurley Capital's portfolio in Q3 2026, its #77 holding.
  • Hurley Capital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 3,191 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.